Acquisition Announced

Axogen acquisition of BioCircuit Technologies

US$200m consideration

Announced 10 Sep 2026

Advisers

BioCircuit Technologies

Target

Financial adviser
Legal adviser

Axogen

Acquirer

Financial adviser
Legal adviser
Target
BioCircuit Technologies
Acquirer
Axogen
Target based in
United States
Buyer based in
United States
Sector
Medtech

In the league tables

Similar deals

All medtech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.